Collectively, our data suggests that obesity drives cardiac hypertrophy per se, while systemic inflammation and metabolic dysfunction promotes adverse effects on cardiac remodeling and function, and these systemic effects were attenuated in Nlrp3−/− and Asc−/− (Pycard−/−) mice. This evidence concerns the gene PYCARD and obesity due to melanocortin 4 receptor deficiency.